[Bayer](https://www.grants-contributions.bayer.com)

Rolling (monthly review; allow minimum 45 days for response)

No fixed amount; budget must be detailed in proposal.

Supports educational programs addressing secondary stroke prevention, with emphasis on novel antithrombotic therapies such as FXIa inhibition.

--- ## Description This grant supports educational initiatives that address critical gaps in secondary stroke prevention, particularly those highlighting the limitations of current antithrombotic treatments and the residual risk of recurrent stroke. Priority is given to programs that educate healthcare professionals on the burden of secondary stroke, introduce FXIa inhibition as a new class of antithrombotic therapy, and review relevant evidence—especially data from the OCEANIC-STROKE trial. The goal is to foster awareness of evolving strategies in stroke prevention and the unique role of FXI in the coagulation cascade. --- ## Due Dates - Applications are accepted on a rolling basis. - Proposals are reviewed monthly; applicants should allow a minimum of 45 days from submission for a response. --- ## Funding Amount - No set funding cap; applicants must submit a detailed budget as part of the proposal. - Funding is determined based on the scope and requirements of the proposed educational program. --- ## Eligibility - Intended for organizations or providers capable of delivering accredited medical education (e.g., CME providers). - Programs must target healthcare professionals such as: - Vascular and general neurologists - Hospitalists - Primary care physicians - Pharmacists - Advanced practice providers (nurses, nurse practitioners, physician assistants, stroke care coordinators) - Cardiologists - Hematologists - Provider must supply a copy of the most recent accreditation letter and status. - Proposals must comply with standards for commercial support (e.g., ACCME guidelines). --- ## Application Process - Submit proposals through the [Bayer Grants & Contributions portal](https://www.grants-contributions.bayer.com/stroke-prevention). - Required proposal components: - Needs assessment - Educational design and rationale - Learning objectives - Proposed faculty - Participant recruitment plan (if applicable) - Outcomes strategy/plan - Detailed budget - Applications are reviewed monthly; allow at least 45 days for a decision. - Grantees must: - Reconcile grant funding within 60 days after program completion - Permit Bayer Medical Affairs to audit live programs - Share activity data and outcomes metrics within 30 days of availability --- ## Additional Information - Highest priority is given to programs focusing on unmet needs in secondary stroke prevention, FXIa inhibition, and incorporation of new evidence (e.g., OCEANIC-STROKE trial results) into clinical practice. - Both live and enduring formats are supported (e.g., Grand Rounds, CME Blasts, conference satellites, chapter meetings). --- ## External Links - [Bayer Grants & Contributions Portal](https://www.grants-contributions.bayer.com/stroke-prevention) - [Bayer Home Page](https://www.grants-contributions.bayer.com) --- ## Contact Information | Type | Details | |-------------------|------------------------------------------------------------------------| | Funder Website | [https://www.grants-contributions.bayer.com](https://www.grants-contributions.bayer.com) | | Address | 100 Bayer Boulevard, Whippany, NJ 07981, USA | For specific inquiries, use the online portal linked above.

Stroke Prevention

Sign in to see full grant listing